Loading
Please wait while we load your information from QuoteMedia.
Loading
Please wait while we load your information from QuoteMedia.
Loading
Please wait while we load your information from QuoteMedia.
Company News
As of May 13, 2025 • 6:31 PM ET
| Date/Time | Source | News Release |
|---|---|---|
| 05/13/2025 07:00 AM EDT | GlobeNewswire | Instil Bio Reports First Quarter 2025 Financial Results and Provides Corporate Update |
| 03/04/2025 07:09 AM EST | GlobeNewswire | Instil Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update |
| 01/14/2025 07:00 AM EST | GlobeNewswire | Instil Bio Announces Clinical Progress in China for IMM2510/SYN-2510, a Clinical-Stage PD-L1xVEGF Bispecific Antibody |
| 11/13/2024 07:00 AM EST | GlobeNewswire | Instil Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update |
Page
- 1
Additional News
As of May 13, 2025 • 6:31 PM ET
| Date/Time | Source | News Release |
|---|---|---|
| 05/13/2025 08:48 AM EDT | SeekingAlpha | Instil Bio Non-GAAP EPS of -$1.32 |
| 05/10/2025 05:31 AM EDT | US Earnings Reports | Expected earnings - Instil Bio Inc. |
| 04/27/2025 02:10 PM EDT | SeekingAlpha | Notable healthcare headlines for the week: Merck, Roche and Bausch Health in focus |
| 04/25/2025 03:25 PM EDT | SeekingAlpha | Merck gains after latest survival data for Summit's cancer drug |
| 04/20/2025 05:02 PM EDT | Stock Traders Daily | (TIL) Trading Report |
| 04/14/2025 05:57 AM EDT | Zacks | Here's Why Summit Therapeutics Stock Soared 15% on Friday |
| 04/04/2025 10:20 AM EDT | Stock Traders Daily | Where are the Opportunities in (TIL) |
| 03/05/2025 10:17 AM EST | SeekingAlpha | Instil Bio Non-GAAP EPS of -$1.82 |
| 03/05/2025 04:31 AM EST | US Earnings Reports | Expected earnings - Instil Bio Inc. |
| 03/03/2025 08:40 PM EST | Stock Traders Daily | When (TIL) Moves Investors should Listen |
Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.